Pathoquest

Today, we want to reaffirm our commitment to support faster and safer access to innovative cancer treatments by providing advanced NGS-solutions for the quality control of biologics. #WorldCancerDay #IamAndIwill worldcancerday.org/

Our NGS-based approach provides a state-of-the-art quality control testing solution for biopharmaceutical quality assurance and production managers. Our new facility in Wayne will create additional opportunities to integrate with Charles River’s service... businesswire.com/news/home/2…

In a thriving effort to enhance its customer services, PathoQuest has obtained the administrative authorization of the Pharmaceutical Establishment from the French ANSM for its biological drug testing activities. Read the full press release: pathoquest.com/?p=57843&prev… #ngs #qc

Don't' miss our 2 talks today during the Viral safety session: *11:40 Dr.Magali Roche - NGS capabilities in term of Biologics QC testing *13:40 Pr.Marc Eloit - NGS innovations for Mycoplasma detection Free passes here>> pathoquest.com/?p=57565 #BPIEUROPE

You can reach our team on our virtual booth Audrey Coiffic and Magali Roche. And don’t miss Dr.Roche’s talk on NGS capabilities in term of Biologics QC testing Thursday 16 July 20 Free pass here >> pathoquest.com/?p=57306 #BPIEUROPE

Come exchange with our experts on our virtual BPI booth this week and don’t miss Dr. Marc Eloit talk on Thursday. Free passes here>> pathoquest.com/?p=57565 #BPIEUROPE

Should your QC program compromises between speed and robustness? Learn how NGS is the right tool to ensure your biologics safety & efficacy with Dr.Magali Roche's talk at BPI (16 July 20) Get your free virtual exhibition pass (13-17 July 20) >> pathoquest.com/?p=57565 #BPIEUROPE

Want to learn more about NGS innovations for Mycoplasma detection? Get your free virtual exhibition pass to next BPI event (13-17 July 20) >> pathoquest.com/?p=57565 #NGS #BPIEUROPE

PathoQuest Announces Appointment of Laurent Lafferrere as Chief Operating Officer >> pathoquest.com/?p=57459

@TransgeneSA chooses @Pathoquest innovative NGS-based safety release test for TG4050 phase I clinical trial targeting patients with head-neck and ovarian cancers and for Invir IO™ recombinant viral vector manufacturing platform >> pathoquest.com/?p=57430 #NGS #QC

PathoQuest’s Paris-based facility obtains GLP certificate for its biologics genomic quality control testing service. PathoQuest is the first company in France to receive such a certificate from the ANSM for advanced NGS viral safety testing. Full PR >> businesswire.com/news/home/2…

PathoQuest is proud to again be a sponsor of the International Conference on Clinical Metagenomics. The 4th Edition of this meeting (ICCMg4) is being held 17-18 October 2019 in Geneva, Switzerland. clinicalmetagenomics.org/ #ngs #metagenomics @IccMg

PathoQuest's CEO Jean-François Brepson discusses the company's efforts with iDTECT Blood in a new Illumina Genomics Podcast "NGS and New Frontiers in Infectious Disease" bit.ly/illumina-pathoquest-p… (Episode 53) #NGS #illumina #antimicrobialresistance #antibioticstewardship

Register for our upcoming September 10th webinar: Cell Testing for Adventitious Viruses: A Game Changing Approach using High-Throughput Sequencing @ bit.ly/pathoquestwebinar10se… #PathoQuest #BGS #NGS

Read our Latest Newsletter – Learn What’s New with PathoQuest’s Biologics Genomic Service. You can view the newsletter at lnkd.in/egmG36P #PathoQuest #NGS #viralsafety #biologics

Learn about our new NGS method for virus testing of cell and visit our booth at the @PDA_Europe Advanced Therapy Medical Products meeting in Vilnius, Lithuania. lnkd.in/ftEqeNz #Pathoquest #NGS #viralsafety #biologics #PDA